SENSEX NIFTY

Glenmark Pharmaceuticals

May 21, 2015 at 12:32 | Source: PTI
Lennox-Gastaut syndrome is a form of childhood-onset epilepsy. "Glenmark has been granted tentative approval last week by the United States Food and Drug Administration (USFDA) for its Rufinamide tablets," the company said in a BSE filing.
May 21, 2015 at 09:34 | Source: Moneycontrol.com
Glenmark Pharmaceutical has been granted tentative approval last week by USFDA for its Rufinamide Tablets USP, 200 mg and 400 mg.
May 20, 2015 at 13:08 | Source: CNBC-TV18
R Sreesankar, Head-Institutional Equities at Prabhudas Lilladher is of the view that Glenmark Pharma, Dr Reddy's Laboratories and Aurobindo Pharma are the top picks from the pharma space.
May 20, 2015 at 10:44 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Glenmark Pharma and hold the stock for a few days.
May 15, 2015 at 21:34 | Source: Moneycontrol.com
Glenmark Pharmaceuticals' baord meeting will be held on May 29, 2015 to consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2015. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2015.
Apr 22, 2015 at 14:17 | Source: CNBC-TV18
Ashish Chaturmohta of Fortune Group recommends going long in Glenmark Pharma and Aurobindo Pharma.
Apr 22, 2015 at 12:46 | Source: CNBC-TV18
The pharma space has been in focus post Sun Pharma-Daiichi deal and the likelihood of a possible merger between Teva and Mylan globally. In an interview to CNBC-TV18, Abhishek Sharma of IIFL discusses his outlook on the sector and on specific companies.
Apr 20, 2015 at 10:49 | Source: CNBC-TV18
Ajay Bodke of Prabhudas Lilladher is positive on Glenmark Pharma and expects target price at around Rs 1186 over a one year period.
Apr 20, 2015 at 10:35 | Source: Moneycontrol.com
Based on the deal with Temasek and visibility of a superior earnings profile following US approvals and out-licensing of NCE/NBE molecules Macquarie has raised Glenmark's target price to Rs 1400 per share while maintining outperform rating.
Apr 20, 2015 at 08:54 | Source: Moneycontrol.com
Pharma sector will continue getting strong astrological support. Buy Cipla, Glenmark Pharma, Sun Pharma, Divis Lab, Ajanta Pharma, Wockhardt etc, says Satish Gupta of Astrostocktips.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

7774 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7774 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7774 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7774 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd 2014

BSE/NSE Announcer

Platinum Member

7774 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th 2014

adviserbola

Platinum Member

353 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th 2014

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th 2014

Amrita Gaba

New Member

416 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th 2014

BSE/NSE Announcer

Platinum Member

7774 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th 2014

News across the web »
Apr 18, 2015 at 03:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.